IPRIPR2026-00168Institution Denied
Sarepta Therapeutics, Inc. et al.v.Genzyme Corporation et al.
IPR challenge of US 12123880.
Type
IPR
Filed
Dec 2, 2025
Instituted
May 15, 2026
Decided
May 15, 2026
Patent
Application
18321542
Inventor
Xiaoying JIN et al
Granted
Oct 22, 2024
01
Timeline
3 milestones
2025-12-02Petition filed
2026-05-15Institution
2026-05-15Terminated
02
Parties & counsel
Petitioner
Sarepta Therapeutics, Inc. et al.
Counsel
Wilson, Robertet al
Patent Owner
Genzyme Corporation et al.
Counsel
Antons, Amandaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →